Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOC2: Elemental diet to prevent oral mucositis in DCF-treated esophageal cancer
jRCTs071180029Phase 3Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Feb 2017
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in esophageal cancer and stomatitis (2 arms), sponsored by EA Pharma Co., Ltd. Primary endpoint: Incidence of oral mucositis grade ≥2. Started Feb 2017; status: completed.
02
Conditions
esophageal cancerstomatitis
Beyond the preview
Go deeper on jRCTs071180029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180029.